Vorapaxar for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction
Vorapaxar for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction
Country | Agency | Status | Link | Details on adaptation process | Contact information |
---|---|---|---|---|---|
Croatia | AAZ | 2015 | Summary of information from the report for decision makers | Mirjana Huic (Mirjana.Huic@aaz.hr) |